Two new studies are gearing up at LA BioMed for IPF patients to begin mid-2019.
“There are some small hints in the scientific literature that exercise training, as part of a pulmonary rehabilitation program, might help to slow the rapid decline in lung function seen in some IPF patients.”
– Principal Investigator, Dr. Harry Rossiter.
PERF board members, Dr. William Stringer and Dr. Harry Rossiter hope to identify whether reducing inflammation through exercise training – either on its own, or combined with anti-inflammatory medication – may potentially protect against lung function decline and ameliorate the negative effects of comorbid conditions.
Those interested in this topic should read The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.